Every major player in your health system gets a direct line to the industry’s most-needed insights and
the support to take action. Learn about our research platform.
Attract and retain the patients you aspire to serve by offering the care network, access, and experience they need. See how we can help.
Improve quality and outcomes and lower costs by eliminating unwarranted deviation from the best standard of care. See how we can help.
Sustain the financial stability to serve your community by making sure you’re paid efficiently for services rendered. See how we can help.
Make sure every level of your organization understands best practice performance and has the tools
and support to get there. Learn about our research platform.
Pinpoint your opportunities and hardwire best practices to accelerate progress. Learn about our technology.
Partner with seasoned experts providing strategic, customized support. Learn about our consulting services.
As an executive director, Brian Contos oversees the Advisory Board’s clinical research and insights programs. Brian has worked with the Advisory Board since 2000, researching and presenting findings on topics that include service line finances, clinical quality, strategic planning, program operations, technology evaluation, and regulatory policy.
He has also authored a variety of studies, including Reducing Preventable Readmissions, Innovation and the Outmigration of Care, and Vascular Centers of Excellence.
Brian studied molecular and developmental biology at Yale University. His previous work includes infectious disease research at the Lippard Laboratory for Clinical Investigation at the Yale School of Medicine and cancer research at the Walt Disney Memorial Cancer Institute at Florida Hospital.
Whether you're motivated by the new value-based health care economy or old-school fee-for-service medicine, expanding your referral network and improving access can pay dividends. But how do you measure success? More
Looking to enter the TAVR market or benchmark your program? We’ve updated our TAVR benchmarks with the latest Medicare data for FY 2014. Find out how the market and practice patterns have changed since TAVR was first approved. More